Literature DB >> 29168004

Diffusion-weighted imaging of the prostate: should we use quantitative metrics to better characterize focal lesions originating in the peripheral zone?

Thibaut Pierre1, Francois Cornud2,3, Loïc Colléter4, Frédéric Beuvon5, Frantz Foissac6, Nicolas B Delongchamps7, Paul Legmann1.   

Abstract

PURPOSE: To compare inter-reader concordance and accuracy of qualitative diffusion-weighted (DW) PIRADSv2.0 score with those of quantitative DW-MRI for the diagnosis of peripheral zone prostate cancer.
MATERIALS AND METHODS: Two radiologists independently assigned a DW-MRI-PIRADS score to 92 PZ-foci, in 74 patients (64.3±5.6 years old; median PSA level: 8 ng/ml, normal DRE in 70 men). A standardised ADCmean and nine ADC-derived parameters were measured, including ADCratios with the whole-prostate (WP-ADCratio) or the mirror-PZ (mirror-ADCratio) as reference areas. Surgical histology and MRI-TRUS fusion-biopsy were the reference for tumours and benign foci, respectively. Inter-reader agreement was assessed by the Cohen-kappa-coefficient and the intraclass correlation coefficient (ICC). Univariate-multivariate regressions determined the most predictive factor for cancer.
RESULTS: Fifty lesions were malignant. Inter-reader concordance was fair for qualitative assessment, but excellent for quantitative assessment for all quantitative variables. At univariate analysis, ADCmean, WP-ADCratio and WL-ADCmean performed equally, but significantly better than the mirror-ADCratio (p<0.001). At multivariate analysis, the only independent variable significantly associated with malignancy was the whole-prostate-ADCratio. At a cut-off value of 0.68, sensitivity was 94-90 % and specificity was 60-38 % for readers 1 and 2, respectively.
CONCLUSION: The whole-prostate-ADCratio improved the qualitative inter-reader concordance and characterisation of focal PZ-lesions. KEY POINTS: • Inter-reader concordance of DW PI-RADSv2.0 score for PZ lesions was only fair. • Using a standardised ADCmean measurement and derived DW-quantitative parameters, concordance was excellent. • The whole-prostate ADCratio performed significantly better than the mirror-ADCratio for cancer detection. • At a cut-off of 0.68, sensitivity values of WP-ADCratio were 94-90 %. • The whole-prostate ADCratio may circumvent variations of ADC metrics across centres.

Entities:  

Keywords:  Adult; Diffusion magnetic resonance imaging/methods; Prostatic neoplasms/diagnostic imaging; Retrospective studies; Sensitivity and specificity

Mesh:

Year:  2017        PMID: 29168004     DOI: 10.1007/s00330-017-5107-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  34 in total

1.  3-Dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion.

Authors:  Osamu Ukimura; Mihir M Desai; Suzanne Palmer; Samuel Valencerina; Mitchell Gross; Andre L Abreu; Monish Aron; Inderbir S Gill
Journal:  J Urol       Date:  2012-01-21       Impact factor: 7.450

2.  Quantitative evaluation of computed high B value diffusion-weighted magnetic resonance imaging of the prostate.

Authors:  Marnix C Maas; Jurgen J Fütterer; Tom W J Scheenen
Journal:  Invest Radiol       Date:  2013-11       Impact factor: 6.016

3.  Prostate MRI: evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score.

Authors:  Olivio F Donati; Asim Afaq; Hebert Alberto Vargas; Yousef Mazaheri; Junting Zheng; Chaya S Moskowitz; Hedvig Hricak; Oguz Akin
Journal:  Clin Cancer Res       Date:  2014-05-21       Impact factor: 12.531

4.  Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T.

Authors:  Klaas N A Nagel; Martijn G Schouten; Thomas Hambrock; Geert J S Litjens; Caroline M A Hoeks; Bennie ten Haken; Jelle O Barentsz; Jurgen J Fütterer
Journal:  Radiology       Date:  2013-01-17       Impact factor: 11.105

5.  Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm²) and standard high b-value (1000 s/mm²).

Authors:  Kazuhiro Kitajima; Satoru Takahashi; Yoshiko Ueno; Takeshi Yoshikawa; Yoshiharu Ohno; Makoto Obara; Hideaki Miyake; Masato Fujisawa; Kazuro Sugimura
Journal:  J Magn Reson Imaging       Date:  2012-02-27       Impact factor: 4.813

6.  Tumor target volume for focal therapy of prostate cancer-does multiparametric magnetic resonance imaging allow for a reliable estimation?

Authors:  F Cornud; Gaby Khoury; Naim Bouazza; Frederic Beuvon; Michael Peyromaure; Thierry Flam; Marc Zerbib; Paul Legmann; Nicolas B Delongchamps
Journal:  J Urol       Date:  2013-12-12       Impact factor: 7.450

7.  What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T?

Authors:  T Metens; D Miranda; J Absil; C Matos
Journal:  Eur Radiol       Date:  2011-10-05       Impact factor: 5.315

8.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

Authors:  Hashim U Ahmed; Ahmed El-Shater Bosaily; Louise C Brown; Rhian Gabe; Richard Kaplan; Mahesh K Parmar; Yolanda Collaco-Moraes; Katie Ward; Richard G Hindley; Alex Freeman; Alex P Kirkham; Robert Oldroyd; Chris Parker; Mark Emberton
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321

9.  Conspicuity of peripheral zone prostate cancer on computed diffusion-weighted imaging: comparison of cDWI1500, cDWI2000, and cDWI3000.

Authors:  Metin Vural; Gökhan Ertaş; Aslıhan Onay; Ömer Acar; Tarık Esen; Yeşim Sağlıcan; Hale Pınar Zengingönül; Sergin Akpek
Journal:  Biomed Res Int       Date:  2014-12-01       Impact factor: 3.411

10.  Predicting Prostate Biopsy Outcomes: A Preliminary Investigation on Screening with Ultrahigh B-Value Diffusion-Weighted Imaging as an Innovative Diagnostic Biomarker.

Authors:  Kun Zhang; Yanguang Shen; Xu Zhang; Lu Ma; Haiyi Wang; Ningyu An; Aitao Guo; Huiyi Ye
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

View more
  3 in total

1.  Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.

Authors:  Xuefu Ji; Jiayi Zhang; Yuguo Tang; Wei Xia; Wei Shi; Dong He; Jie Bao; Xuedong Wei; Yuhua Huang; Yangchuan Liu; Jyh-Cheng Chen; Xin Gao
Journal:  Phys Eng Sci Med       Date:  2021-06-01

2.  Non-timely clinically applicable ADC ratio in prostate mpMRI: a comparison with fusion biopsy results.

Authors:  Zeno Falaschi; Stefano Tricca; Silvia Attanasio; Michele Billia; Chiara Airoldi; Ilaria Percivale; Simone Bor; Davide Perri; Alessandro Volpe; Alessandro Carriero
Journal:  Abdom Radiol (NY)       Date:  2022-08-09

3.  Discrimination between clinical significant and insignificant prostate cancer with apparent diffusion coefficient - a systematic review and meta analysis.

Authors:  Hans-Jonas Meyer; Andreas Wienke; Alexey Surov
Journal:  BMC Cancer       Date:  2020-05-27       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.